Loading
GI
Genvec Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by MMCAP International Inc. SPC, was filed 14 Mar 2017.
Genvec Inc: what insiders have been doing
Every trade that managers of Genvec Inc disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Genvec Inc in twelve months, the latest record being from 20 June 2017.
Looking back to 2016, when coverage begins, insiders filed 5 purchases and no sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
34
Thresholds
n/a
Buy Volume
€145,953
5 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2013FY ended December 2013 · cache
Income statement
Revenue3.3M
Net income-5.2M-157.2% margin
Last declaration on 20 June 2017
Declarations34 total
1,500 shares@ US$3.80100.0% of flowCommon StockSEC:0001123292-17-001159:0
1,500 shares@ US$3.8050.0% of flowCommon StockSEC:0001123292-17-001163:0
793 shares@ US$7.1950.0% of flowCommon StockSEC:0001123292-17-001163:1
793 shares@ US$7.1950.0% of flowCommon StockSEC:0001123292-17-001165:1
1,500 shares@ US$3.80100.0% of flowCommon StockSEC:0001123292-17-001166:0
25,000 shares@ US$5.6096.6% of flowCommon StockSEC:0001123292-17-001160:0
2,250 shares@ US$3.8050.0% of flowCommon StockSEC:0001123292-17-001162:0
1,189 shares@ US$7.1950.0% of flowCommon StockSEC:0001123292-17-001162:1
6,000 shares@ US$5.60100.0% of flowCommon StockSEC:0001123292-17-001167:0
4,000 shares@ US$5.60100.0% of flowCommon StockSEC:0001123292-17-001164:0
793 shares@ US$7.19Common StockSEC:0001123292-17-001159:1
793 shares@ US$7.19Common StockSEC:0001123292-17-001166:1
793 shares@ US$7.19Common StockSEC:0001123292-17-001161:1
20,930 shares@ US$7.19Common StockSEC:0001123292-17-001160:1
4,710 shares@ US$7.19Common StockSEC:0001123292-17-001167:1
3,115 shares@ US$7.19Common StockSEC:0001123292-17-001164:1
13,000 shares@ US$5.60100.0% of flowCommon StockSEC:0001123292-17-001168:0
1,061 sharesCommon StockSEC:0001123292-17-001162:2
1,207 sharesCommon StockSEC:0001123292-17-001159:2
707 sharesCommon StockSEC:0001123292-17-001163:2
1,500 shares@ US$3.8050.0% of flowCommon StockSEC:0001123292-17-001165:0
8,257 sharesCommon StockSEC:0001123292-17-001165:2
8,507 sharesCommon StockSEC:0001123292-17-001166:2
1,500 shares@ US$3.80100.0% of flowCommon StockSEC:0001123292-17-001161:0
8,257 sharesCommon StockSEC:0001123292-17-001161:2
25 of 34 declarations
About Genvec Inc
Genvec Inc is a company listed on the XNAS market, specializing in gene therapy development. It focuses on innovative solutions for treating various diseases.
